Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 1, 2002, Pages 58-66

  Kapp, Karin S ^a,c   Poschauko, Johann ^a   Geyer, Edith ^a   Berghold, Andrea ^a   Oechs, Astrid C ^a   Petru, Edgar ^a   Lahousen, Manfred ^a   Kapp, Daniel S ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Karl Franzens University Medical School   (Australia)

Author keywords

Cervix cancer; Hemoglobin; Prognostic factors; Radiotherapy; Transfusion

Indexed keywords

RADIOCURABILITY;

PATIENT TREATMENT; RADIOTHERAPY;

ONCOLOGY;

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FOLLOW UP; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CANCER;

ANEMIA; DISEASE-FREE SURVIVAL; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 0036716856     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02896-1     Document Type: Article

References (45)

1. The influence of anemia on the results of radiotherapy in carcinoma of the cervix
2. Anemia as a prognostic factor in cancer of the cervix: A preliminary report
3. Association of hemoglobin levels before and during radiotherapy with prognosis in uterine cervix cancer
4. Current status of treatment of localized disease and future aspects
5. The significance of anemia in clinical radiation therapy
6. Pretreatment prognostic factors in carcinoma of the uterine cervix: A multivariate analysis of the effect of age, stage, histology and blood counts on survival
7. High-dose rate intracavitary therapy for carcinoma of the uterine cervix: I. General figures of survival and complications
8. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patients
9. Prognostic assessment of tumor regression after external irradiation for cervical cancer
10. Stage IB or IIA-B carcinoma of the intact uterine cervix treated with irradiation: A multivariate analysis
11. Prognostic factors in patients with cervix cancer treated by radiation therapy: Results of multiple regression analysis
12. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone
13. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma
14. High-dose-rate intracavitary irradiation using linear source arrangement for stage II and III squamous cell carcinoma of the uterine cervix
15. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix
16. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
17. Anemia: A problem or an opportunity in radiotherapy?
18. Chemical sensitizers for hypoxic cells: A decade of experience in clinical radiotherapy
19. Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix
20. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers
21. Irradiation with or without misonidazol for patients with stages IIIB and IVA carcinoma of the cervix: Final results of RTOG 80-85
22. Carcinoma of the cervix - Anemia, radiotherapy and hyperbaric oxygen
23. Increased radiosensitivity by perfluorochemicals and carbogen
24. SR 4233 (tirapazamine): A new anticancer drug exploiting hypoxia in solid tumours
25. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Preliminary results of a randomized, open-labeled, phase II trial
26. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer
27. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and Ir-192 high-dose-rate brachytherapy
28. Dosimetry of intracavitary placements for uterine and cervical carcinoma: Results of orthogonal film, TLD, and CT-assisted techniques
29. Non-parametric estimations from incomplete observations
30. Regression models and life tables
31. A possible association between survival time and transfusion in cervical cancer
32. Perioperative blood transfusion increases the risk of recurrence in colorectal cancer
33. Blood transfusion - Modulated tumor recurrence: First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal surgery
34. Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer
35. Anemia, hypoxia and transfusion in patients with cervix cancer: A review
36. Carcinoma of the cervix treated with radiation therapy I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group
37. The effect of anemia on the fraction of hypoxic cells in an experimental tumour
38. Cancer-related anemia: Its causes and characteristics
39. Anemia of cancer
40. Prediction of response to optimize outcome of treatment with erythropoietin
41. Concurrent chemotherapy and radiation for locally advanced cervical cancer: The new standard of care
42. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma. Preliminary results
43. Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy